James P. Theiler

This paper develops updated HIV-1 pseudovirus panels to better detect and assess B cell lineages with potential to produce broadly neutralizing antibodies against contemporary HIV-1 variants.

This study evaluates the neutralization escape of the SARS-CoV-2 Omicron subvariant BA.2.86 compared to other variants, finding lower neutralization by antibodies than BA.2 but comparable to circulating variants.

The paper models cross-neutralization profiles of SARS-CoV-2 sera against variants by analyzing mutations and shows that a third dose of mRNA-1273 improves neutralization breadth.

This paper analyzes global SARS-CoV-2 variant transitions from 2020-2022, finding associations with vaccination rates, co-circulating variants, and natural immunity.

The paper identifies two lineages of Monkeypox virus in the U.S. in 2021-2022, finding a common ancestor and evidence of APOBEC3 editing in West African strains.